bromouracil has been researched along with Maxillary Neoplasms in 1 studies
Bromouracil: 5-Bromo-2,4(1H,3H)-pyrimidinedione. Brominated derivative of uracil that acts as an antimetabolite, substituting for thymine in DNA. It is used mainly as an experimental mutagen, but its deoxyriboside (BROMODEOXYURIDINE) is used to treat neoplasms.
5-bromouracil : A pyrimidine having keto groups at the 2- and 4-positions and a bromo group at the 5-position. Used mainly as an experimental mutagen.
Maxillary Neoplasms: Cancer or tumors of the MAXILLA or upper jaw.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Egawa, S | 1 |
1 other study available for bromouracil and Maxillary Neoplasms
| Article | Year |
|---|---|
[RRadiotherapy and radio-sensitizing agents].
Topics: Bromouracil; Fluorouracil; Humans; Maxillary Neoplasms; Radiation-Sensitizing Agents; Radiotherapy | 1971 |